Digipath Inc
OTC:DIGP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Digipath Inc
Cash & Cash Equivalents
Digipath Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Digipath Inc
OTC:DIGP
|
Cash & Cash Equivalents
$1.1m
|
CAGR 3-Years
111%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash & Cash Equivalents
$393m
|
CAGR 3-Years
31%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
12%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash & Cash Equivalents
$8.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
|
Cigna Corp
NYSE:CI
|
Cash & Cash Equivalents
$7.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
15%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash & Cash Equivalents
$532.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-3%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Cash & Cash Equivalents
$378.2m
|
CAGR 3-Years
39%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Digipath Inc
Glance View
DigiPath, Inc. engages in the provision of cannabis testing, education, training, and news coverage. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2011-12-23. The Company’s cannabis testing business is operated through its subsidiary, Digipath Labs, Inc., which performs all cannabis related testing using FDA-compliant laboratory equipment and processes. The firm is a third-party independent testing laboratory facility for cannabis, cannabis infused products, hemp and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients and eventually all end users of cannabis and botanical products. Its Digipath Labs screens medicinal and recreational cannabis for harmful contaminants, including residual solvents, moisture, water activity, visual inspection, pesticides, heavy metals, biological toxins and microbial contaminants.
See Also
What is Digipath Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.1m
USD
Based on the financial report for Mar 31, 2024, Digipath Inc's Cash & Cash Equivalents amounts to 1.1m USD.
What is Digipath Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
16%
Over the last year, the Cash & Cash Equivalents growth was 818%. The average annual Cash & Cash Equivalents growth rates for Digipath Inc have been 111% over the past three years , 16% over the past five years .
